AEON Biopharma (AEON) Assets (2020 - 2026)
AEON Biopharma (AEON) posted Assets of $5.6 million for Q4 2025, down 36.34% sequentially from $8.7 million in Q3 2025, and up 76.96% YoY from $3.1 million in Q4 2024.
AEON Biopharma (AEON) Assets (2020 - 2026) Analysis & Trends
AEON Biopharma has reported Assets for 6 years, with the latest figure at $5.6 million in Q4 2025.
- Quarterly Assets rose 76.96% year-over-year to $5.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.6 million (up 76.96% YoY) and the FY2025 annual result came in at $5.6 million, up 76.96% from the prior year.
- Assets fell to $5.6 million in Q4 2025 per AEON's latest filing, from $8.7 million in the prior quarter.
- Over five years, Assets peaked at $278.1 million in Q1 2021 and troughed at $3.0 million in Q1 2024.
- A 5-year average of $103.7 million and a median of $15.7 million in 2023 frame the typical range for Assets.
- The sharpest annual moves came in 2021 and 2022: Assets surged 341813.0% in 2021, then slumped 96.11% in 2022.
- Over 5 years, Assets stood at $276.9 million in 2021, then plunged by 96.11% to $10.8 million in 2022, then sank by 36.49% to $6.8 million in 2023, then tumbled by 54.1% to $3.1 million in 2024, then surged by 76.96% to $5.6 million in 2025.
- According to Business Quant data, Assets over the past three periods registered $5.6 million, $8.7 million, and $11.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | AEON Biopharma | 9.71 Mn | 6.28 Mn | - | 5.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.91 Mn |
| Dec 31, 2025 | 5.56 Mn |
| Sep 30, 2025 | 8.73 Mn |
| Jun 30, 2025 | 11.66 Mn |
| Mar 31, 2025 | 13.80 Mn |
| Dec 31, 2024 | 3.14 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 5.73 Mn |
| Mar 31, 2024 | 3.03 Mn |
| Dec 31, 2023 | 6.85 Mn |
| Sep 30, 2023 | 17.62 Mn |
| Jun 30, 2023 | 21.79 Mn |
| Mar 31, 2023 | 21.62 Mn |
| Dec 31, 2022 | 10.78 Mn |
| Sep 30, 2022 | 277.32 Mn |
| Jun 30, 2022 | 276.51 Mn |
| Mar 31, 2022 | 276.65 Mn |
| Dec 31, 2021 | 276.95 Mn |
| Sep 30, 2021 | 277.20 Mn |
| Jun 30, 2021 | 277.62 Mn |